50 results on '"IMMUNOCOMPROMISED patients"'
Search Results
2. Patients with immune mediated inflammatory diseases are insufficiently protected against vaccine-preventable infections
3. Comparing the diagnostic value of targeted with metagenomic next-generation sequencing in immunocompromised patients with lower respiratory tract infection
4. Case reports of persistent SARS-CoV-2 infection outline within-host viral evolution in immunocompromised patients
5. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications
6. Severe Legionnaires’ disease
7. ICU-acquired infections in immunocompromised patients
8. Longevity of the humoral and cellular responses after SARS-CoV-2 booster vaccinations in immunocompromised patients
9. Protection of inactivated vaccine against SARS-CoV-2 infections in patients with comorbidities: a prospective cohort study
10. Fatal BK polyomavirus-associated pneumonia: report of two cases with literature review
11. Antibiotic resistance, biofilm formation, and virulence genes of Streptococcus agalactiae serotypes of Indian origin
12. Neoehrlichia mikurensis in Danish immunocompromised patients: a retrospective cohort study
13. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing
14. Features of Interferon Status and Methods of Its Correction in the Treatment of Patients with Atypical Chronic Active Herpesvirus Infections
15. Observational Study on Clinical Features and Management of Skull Base Osteomyelitis in Hospitalised Patients at a Tertiary Care Hospital
16. Impact of Chronic Immunosuppression on Short-, Mid-, and Long-Term Bariatric Surgery Outcomes
17. Outcomes and factors contributing to poor prognosis of Pneumocystis jirovecii pneumonia in HIV-negative patients: a cross-sectional retrospective study in a Chinese single center
18. Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients
19. SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders
20. The unmet need for COVID-19 treatment in immunocompromised patients
21. Association between Blastocystis sp. infection and immunocompromised patients: a systematic review and meta-analysis
22. Molecular detection of Cystoisospora belli by single-run polymerase chain reaction in stool samples
23. Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients
24. Sapovirus detection and quantification in fecal samples from allogeneic hematopoietic stem cell transplant recipients
25. Challenging TaqMan probe-based real-time PCR and loop-mediated isothermal amplification (LAMP): the two sensitive molecular techniques for the detection of toxoplasmosis, a potentially dangerous opportunistic infection in immunocompromised patients
26. Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls
27. Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea
28. The fate of immunocompromised patients in the treatment of chronic periprosthetic joint infection: a single-centre experience
29. Impact of a guideline-based best practice alert on pneumococcal vaccination rates in adults in a primary care setting
30. Clinical and economic burden of pneumococcal disease in US adults aged 19–64 years with chronic or immunocompromising diseases: an observational database study
31. Cutaneous Manifestations of Infections in Solid Organ Transplant Recipients
32. Immunocompromised patients with acute respiratory distress syndrome: secondary analysis of the LUNG SAFE database
33. Isolation and molecular characterization of Acanthamoeba strains isolated from the oral cavity of immunosuppressed individuals in Tehran, Iran
34. Epidemiology of Scedosporiosis
35. Prevention of Biliary Leakage after Removal of T-tube in Immunocompromised Patients
36. Evidence of Pneumocystis jiroveci in human clinical samples in southwestern Slovakia over a 10-year period (2001–2010)
37. Usefulness of the Serum Galactomannan Assay for Early Response Assessment and Treatment Stratifications of Invasive Aspergillosis
38. Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience
39. An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients
40. Radiological Features of Pneumocystis jirovecii Pneumonia in Immunocompromised Patients with and Without AIDS
41. Bilateral tuberculous otomastoiditis in an immmunocompetent 5-year-old child: CT and MRI findings (2009: 3b)
42. Clinical features of immunocompromised and nonimmunocompromised patients with pulmonary tuberculosis
43. Unusual Merkel cell carcinoma in a renal transplant recipient: case report and review of the literature
44. Isolation of Helicobacter cinaedi from blood of an immunocompromised patient in Japan
45. Infections gastro-intestinales chez le patient immunocompromis
46. Diagnosing Human Parvovirus B19 Infection: Guidelines for Test Selection
47. Necrotizing cervical fasciitis: a case report and review of literature
48. Angioimmunoblastic lymphadenopathy with disseminated human herpesvirus 6 infection in a patient with acute myeloblastic leukemia
49. Postoperative infections in immunocompromised patients after oncological surgery
50. Respiratory syncytial virus, a rare cause of severe pneumonia following bone marrow transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.